2020 PCF Challenge Award
177Lu-PSMA-617 as a Radioimmunotherapy for Prostate Cancer
Principal Investigators: Rahul Aggarwal, MD (University of California, San Francisco), Lawrence Fong, MD, (University of California, San Francisco), Michael Evans, PhD (University of California, San Francisco), Thomas Hope, MD (University of California, San Francisco)
Co-Investigators: David Oh, MD, PhD (University of California, San Francisco), Charles Craik, PhD (University of California, San Francisco), Li Zhang, PhD (University of California, San Francisco)
2020 Movember – Distinguished Gentleman’s Ride – PCF Challenge Award
Targeting Transcriptional Addiction in Prostate Cancer by Impeding Neo-Enhancer Accessibility
Principal Investigators: Arul Chinnaiyan, MD, PhD (University of Michigan), Marcin Cieslik, PhD (University of Michigan), Ulka Vaishampayan, MBBS (University of Michigan), Yuzhuo Wang, PhD (University of British Columbia)
Co-Investigators: Lanbo Xiao, PhD (University of Michigan), Abhijit Parolia, PhD (University of Michigan), Yuanyuan Qiao, PhD (University of Michigan), Jeremy Taylor, PhD (University of Michigan)
2020 John Black Charitable Foundation-PCF Challenge Award
Targeting the Host Microbiota to Reverse Therapeutic Resistance in Lethal Prostate Cancers
Principal Investigators: Johann de Bono, MD, PhD (Institute of Cancer Research), Andrea Alimonti, MD (Institute of Oncology Research)
Co-Investigators: Silke Gillessen Sommer, MD (University of Italian Switzerland), Christina Yap, PhD (The Institute of Cancer Research), Arianna Calcinotto, PhD (Institute of Oncology Research), Christina Guo, MBBS (The Royal Marsden NHS Foundation Trust), Bora Gurel, MD (The Institute of Cancer Research), Khobe Chandran, MBBS (The Royal Marsden NHS Foundation Trust), Suzanne Carreira, PhD (The Institute of Cancer Research), Nicolo’ Pernigoni, MSc (Institute of Oncology Research), Pasquale Rescigno, MD (The Institute of Cancer Research)
2020 Janssen-PCF Challenge Award
PARPi Response Evaluation for Clinical Impact and Scientific Innovation in Oncology: The PRECISION Registry
Principal Investigators: Veda Giri, MD (Thomas Jefferson University), Susan Halabi, PhD (Duke University), Alexander Wyatt, PhD (University of British Columbia)
Co-Investigators: Rhonda Bitting, MD (Duke University), Christopher McNair, PhD (Thomas Jefferson University)
2020 John Black Charitable Foundation-PCF Challenge Award
Epitranscriptomic Determinants of Androgen Deprivation Therapy Resistance in Prostate Cancer
Principal Investigators: Nigel Mongan, PhD (University of Nottingham)
Co-Investigators: Victoria James, PhD (University of Nottingham), Catrin Rutland, PhD (University of Nottingham), Emad Rakha, MD (University of Nottingham), Jennie Jeyapalan, PhD (University of Nottingham), Rupert Fray, PhD (University of Nottingham), Nathan Archer, PhD (University of Nottingham), Brian Robinson, MD (Weill Cornell Medicine), Francesca Khani, MD (Weill Cornell Medicine), Simone de Brot, PhD, DVM (University of Bern), Jenny Persson, PhD (Umeå University & Malmö University, Sweden)